Mónica G. M.
- Country
- Spain
- Department
- Department of oncology
Research Overview
- Phase 1/2 Study of EIK1005 Monotherapy and EIK1005 Plus Pembrolizumab in Patients With Advanced Solid Tumors
- Phase 3 Randomized Double-Blind Study of INCA33890 Plus First-Line Chemotherapy and Bevacizumab in Metastatic Microsatellite Stable Colorectal Cancer
- Phase 3 Randomized Study of INCB161734 Plus Combination Chemotherapy Versus Placebo Plus Chemotherapy in KRAS G12D‑Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Data & Insights
Has run more than one trial at 71 of 211 partner sites.
Specializations
Oncological Focus
This investigator specializes in the treatment of squamous cell carcinoma, with particular emphasis on anal canal cancer and its various manifestations, including locally recurrent and metastatic cases.
- Advanced Anal Canal Carcinoma
- Locally Recurrent Disease
- Metastatic Cancer Management
The investigator's work extends to treating patients with non-small cell lung cancer, demonstrating expertise across multiple solid tumor types.
Therapeutic Approaches
The investigator has developed expertise in various treatment modalities, including immunotherapy combinations and chemoradiotherapy for cancer treatment.
- Combined Modality Treatment
- Chemotherapy Protocols
- Immunotherapy Applications
Their work involves both systemic therapy and multimodal treatment approaches for complex oncological cases.
Clinical Assessment
The investigator focuses on evaluating treatment efficacy through comprehensive clinical assessment methods and response criteria.
- Disease-Free Survival Analysis
- Complete Response Assessment
- Treatment Response Monitoring
Expertise includes evaluation of clinical outcomes and therapeutic response patterns in oncology patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.